Cargando…
Cholesterol-Lowering Drugs and Incident Open-Angle Glaucoma: A Population-Based Cohort Study
BACKGROUND: Open-angle glaucoma (OAG) is a progressive neurodegenerative disease that may lead to blindness. An elevated intraocular pressure (IOP) is its major risk factor. OAG treatment is currently exclusively directed towards the lowering of the IOP. IOP lowering does not prevent disease progres...
Autores principales: | Marcus, Michael W., Müskens, Rogier P. H. M., Ramdas, Wishal D., Wolfs, Roger C. W., De Jong, Paulus T. V. M., Vingerling, Johannes R., Hofman, Albert, Stricker, Bruno H., Jansonius, Nomdo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251600/ https://www.ncbi.nlm.nih.gov/pubmed/22238644 http://dx.doi.org/10.1371/journal.pone.0029724 |
Ejemplares similares
-
Nutrient intake and risk of open-angle glaucoma: the Rotterdam Study
por: Ramdas, Wishal D., et al.
Publicado: (2012) -
Incidence of glaucomatous visual field loss after two decades of follow-up: the Rotterdam Study
por: Springelkamp, Henriët, et al.
Publicado: (2017) -
Influence of glaucoma surgery on visual function: a clinical cohort study and meta‐analysis
por: Junoy Montolio, Francisco G., et al.
Publicado: (2018) -
Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature
por: Ramdas, Wishal D., et al.
Publicado: (2018) -
The Baerveldt Glaucoma Drainage Device: Efficacy, Safety, and Place in Therapy
por: Poelman, Huub J, et al.
Publicado: (2020)